Antithrombotic Therapy for Venous Thromboembolic Disease

Barrit, 1960, Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, 1, 1309, 10.1016/S0140-6736(60)92299-6 Kernohan, 1966, Heparin therapy in thromboembolic disease, Lancet, 1, 621, 10.1016/S0140-6736(66)90822-1 Alpert, 1976, Mortality in patients treated for pulmonary embolism, JAMA, 236, 1477, 10.1001/jama.1976.03270140029017 Kanis, 1974, Heparin in the treatment of pulmonary thromboembolism, Thromb Diath Haemorrh, 32, 519, 10.1055/s-0038-1647720 Gallus, 1986, Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism, Lancet, 2, 1293, 10.1016/S0140-6736(86)91431-5 Hull, 1990, Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis, N Engl J Med, 322, 1260, 10.1056/NEJM199005033221802 Harrison, 1997, Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy, Ann Intern Med, 126, 133, 10.7326/0003-4819-126-2-199701150-00006 Crowther, 1999, A randomized trial comparing 5-mg and 10-mg warfarin loading doses, Arch Intern Med, 159, 46, 10.1001/archinte.159.1.46 Kovacs, 2003, Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism: a randomized, double-blind, controlled trial, Ann Intern Med, 138, 714, 10.7326/0003-4819-138-9-200305060-00007 Brill-Edwards, 1993, Establishing a therapeutic range for heparin therapy, Ann Intern Med, 119, 104, 10.7326/0003-4819-119-2-199307150-00002 Levine, 1994, A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin, Arch Intern Med, 154, 49, 10.1001/archinte.1994.00420010073009 Hull, 1992, Optimal therapeutic level of heparin therapy in patients with venous thrombosis, Arch Intern Med, 152, 1589, 10.1001/archinte.1992.00400200027006 Raschke, 1993, The weight-based heparin dosing nomogram compared with a “standard care” nomogram: a randomized controlled trial, Ann Intern Med, 119, 874, 10.7326/0003-4819-119-9-199311010-00002 Cruickshank, 1991, A standard heparin nomogram for the management of heparin therapy, Arch Intern Med, 151, 333, 10.1001/archinte.1991.00400020085018 Anand, 1999, Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times, Arch Intern Med, 159, 2029, 10.1001/archinte.159.17.2029 Brandjes, 1992, Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis, N Engl J Med, 327, 1485, 10.1056/NEJM199211193272103 Levine, 2001, Hemorrhagic complications of anticoagulant treatment, Chest, 119, 108S, 10.1378/chest.119.1_suppl.108S Salzman, 1975, Management of heparin therapy: controlled prospective trial, N Engl J Med, 292, 1046, 10.1056/NEJM197505152922002 Glazier, 1976, Randomized prospective trial of continuous vs intermittent heparin therapy, JAMA, 236, 1365, 10.1001/jama.1976.03270130027021 Wilson, 1979, Heparin therapy: a randomized prospective study, Am Heart J, 97, 155, 10.1016/0002-8703(79)90349-1 Mant, 1977, Haemorrhagic complications of heparin therapy, Lancet, 1, 1133, 10.1016/S0140-6736(77)92388-1 Fagher, 1981, Heparin treatment of deep vein thrombosis: effects and complications after continuous or intermittent heparin administration, Acta Med Scand, 210, 357, 10.1111/j.0954-6820.1981.tb09831.x Wilson, 1981, Heparin therapy in venous thromboembolism, Am J Med, 70, 808, 10.1016/0002-9343(81)90537-4 Hommes, 1992, Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis: a meta-analysis, Ann Intern Med, 116, 279, 10.7326/0003-4819-116-4-279 Lensing, 1995, Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis, Arch Intern Med, 155, 601, 10.1001/archinte.1995.00430060059007 Dolovich, 2000, A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency, Arch Intern Med, 160, 181, 10.1001/archinte.160.2.181 Levine, 1996, A Comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis, N Engl J Med, 334, 677, 10.1056/NEJM199603143341101 Koopman, 1996, Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home: the Tasman Study Group, N Engl J Med, 334, 682, 10.1056/NEJM199603143341102 The Columbus Investigators, 1997, Low-molecular-weight heparin in the treatment of patients with venous thromboembolism, N Engl J Med, 337, 657, 10.1056/NEJM199709043371001 Wells, 2001, Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism, Curr Opin Pulm Med, 7, 360, 10.1097/00063198-200109000-00019 Harrison, 1998, Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin, Arch Intern Med, 158, 2001, 10.1001/archinte.158.18.2001 Merli, 2001, Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease, Ann Intern Med, 134, 191, 10.7326/0003-4819-134-3-200102060-00009 Charbonnier, 1998, Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis, Thromb Haemost, 79, 897, 10.1055/s-0037-1615089 Goldhaber, 1990, Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis, Am J Med, 88, 235, 10.1016/0002-9343(90)90148-7 Lensing, 1994, Rationale and results of thrombolytic therapy for deep vein thrombosis, 875 Ouriel, 2000, Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis, J Vasc Interv Radiol, 11, 295, 10.1016/S1051-0443(07)61420-1 Winter, 1989, Surgical treatment of iliofemoral vein thrombosis technical aspects: possible secondary interventions, Int Angiol, 8, 188 Lansing, 1968, Five-year follow-up study of iliofemoral venous thrombectomy, Ann Surg, 168, 620, 10.1097/00000658-196810000-00009 Decousus, 1998, A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis, N Engl J Med, 338, 409, 10.1056/NEJM199802123380701 Nielsen, 1994, Anticoagulant therapy in deep venous thrombosis: a randomized controlled study, Thromb Res, 73, 215, 10.1016/0049-3848(94)90100-7 The Rembrandt Investigators, 2000, Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: a phase II evaluation, Circulation, 102, 2726, 10.1161/01.CIR.102.22.2726 Schellong, 1999, Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism, Thromb Haemost, 82, 127 Aschwanden, 2001, Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism, Thromb Haemost, 85, 42, 10.1055/s-0037-1612901 Partsch, 2000, Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin, J Vasc Surg, 32, 861, 10.1067/mva.2000.110352 Partsch, 2001, Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation, Vasa, 30, 195, 10.1024/0301-1526.30.3.195 Lagerstedt, 1985, Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis, Lancet, 2, 515, 10.1016/S0140-6736(85)90459-3 Hull, 1979, Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis, N Engl J Med, 301, 855, 10.1056/NEJM197910183011602 Lohr, 1991, Lower extremity calf thrombosis: to treat or not to treat?, J Vasc Surg, 14, 618, 10.1016/0741-5214(91)90184-V Research Committee of the British Thoracic Society, 1992, Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism, Lancet, 340, 873, 10.1016/0140-6736(92)93285-U Schulman, 1995, A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism: Duration of Anticoagulation Trial Study Group, N Engl J Med, 332, 1661, 10.1056/NEJM199506223322501 Levine, 1995, Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis, Thromb Haemost, 74, 606, 10.1055/s-0038-1649783 Hull, 1982, Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis, N Engl J Med, 306, 189, 10.1056/NEJM198201283060401 Lee, 2003, Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer, N Engl J Med, 349, 146, 10.1056/NEJMoa025313 Hull, 2002, A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium [abstract], Blood, 100, 148a Hull, 2001, Safety and efficacy results for a study investigating the long-term out-of-hospital treatment of patients with proximal-vein thrombosis using subcutaneous low-molecular-weight heparin versus warfarin [abstract], Thromb Haemost Hull, 2003, A randomised trial evaluating long-term low-molecular-weight heparin therapy for three months vs. intravenous heparin followed by warfarin sodium in patients with current cancer [abstract], Thromb Haemost, P137a Prandoni, 1996, The long-term clinical course of acute deep venous thrombosis, Ann Intern Med, 125, 1, 10.7326/0003-4819-125-1-199607010-00001 Schulman, 1997, The duration of oral anticoagulant therapy after a second episode of venous thromboembolism: The Duration of Anticoagulation Trial Study Group, N Engl J Med, 336, 393, 10.1056/NEJM199702063360601 Kearon, 1999, A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism, N Engl J Med, 340, 901, 10.1056/NEJM199903253401201 Agnelli, 2001, Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis, N Engl J Med, 345, 165, 10.1056/NEJM200107193450302 Ridker, 2003, Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism, N Engl J Med, 348, 1425, 10.1056/NEJMoa035029 Kearon, 2003, Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism, N Engl J Med, 349, 631, 10.1056/NEJMoa035422 van Den Belt, 1997, Recurrence of venous thromboembolism in patients with familial thrombophilia, Arch Intern Med, 157, 2227, 10.1001/archinte.1997.00440400077009 Crowther, 2003, Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system, Ann Intern Med, 138, 128, 10.7326/0003-4819-138-2-200301210-00014 Simioni, 1997, The risk of recurrent venous thromboembolism in patients with an Arg506–> Gln mutation in the gene for factor V (factor V Leiden), N Engl J Med, 336, 399, 10.1056/NEJM199702063360602 Kyrle, 2000, High plasma levels of factor VIII and the risk of recurrent venous thromboembolism, N Engl J Med, 343, 457, 10.1056/NEJM200008173430702 Schulman, 1998, Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy: Duration of Anticoagulation Study Group, Am J Med, 104, 332, 10.1016/S0002-9343(98)00060-6 Khamashta, 1995, The management of thrombosis in the antiphospholipid-antibody syndrome, N Engl J Med, 332, 993, 10.1056/NEJM199504133321504 Prandoni, 2002, Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism, Ann Intern Med, 137, 955, 10.7326/0003-4819-137-12-200212170-00008 Eichinger, 2003, D-dimer levels and risk of recurrent venous thromboembolism, JAMA, 290, 1071, 10.1001/jama.290.8.1071 De Stefano, 1999, The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation, N Engl J Med, 341, 801, 10.1056/NEJM199909093411104 Hull, 1982, Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis, N Engl J Med, 307, 1676, 10.1056/NEJM198212303072704 Crowther, 2003, A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome, N Engl J Med, 349, 1133, 10.1056/NEJMoa035241 Schulman, 2003, Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran, N Engl J Med, 349, 1713, 10.1056/NEJMoa030104 Kahn, 2002, The post-thrombotic syndrome: current knowledge, controversies, and directions for future research, Blood Rev, 16, 155, 10.1016/S0268-960X(02)00008-5 Kahn, 2002, Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis, Arch Intern Med, 162, 1144, 10.1001/archinte.162.10.1144 Brandjes, 1997, Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis, Lancet, 349, 759, 10.1016/S0140-6736(96)12215-7 Prandoni, 2002, Below-knee compression stockings for prevention of the post-thrombotic syndrome: a randomized study [abstract], Pathophysiol Haemost Thromb, 32, 72 Ginsberg, 2001, Prevention and treatment of postphlebitic syndrome: results of a 3-part study, Arch Intern Med, 161, 2105, 10.1001/archinte.161.17.2105 Ginsberg, 1999, Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study, Can Med Assoc J, 160, 1303 de Jongste, 1989, A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome, Thromb Haemost, 62, 826, 10.1055/s-0038-1651011 Pittler, 1998, Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review, Arch Dermatol, 134, 1356, 10.1001/archderm.134.11.1356 Catania, 1996, Preliminary comparison of the clinical efficacy and tolerability of low-molecular-weight dermatan sulfate and calcium heparin in postthrombotic syndrome, Curr Ther Res, 57, 969, 10.1016/S0011-393X(96)80115-9 Andreozzi, 1996, Postphlebitic syndrome: clinical activity and tolerability of desmin, new LMW dermatan sulfate, Angiology, 47, 1001, 10.1177/000331979604701009 Monreal, 1994, A prospective study of the long-term efficacy of two different venoactive drugs in patients with post-thrombotic syndrome, Phlebology, 9, 37, 10.1177/026835559400900111 Verardi, 1988, Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebitic syndrome: LMW-heparin versus standard heparin, Int Angiol, 7, 33 Morl, 1986, Treatment of postthrombotic syndrome with a mixture of enzymes [in German], Therapiewoche, 36, 2443 Douketis, 1998, Risk of fatal pulmonary embolism in patients with treated venous thromboembolism, JAMA, 279, 458, 10.1001/jama.279.6.458 Hull, 2000, Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism: American-Canadian Thrombosis Study Group, Arch Intern Med, 160, 229, 10.1001/archinte.160.2.229 Simonneau, 1997, A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism, N Engl J Med, 337, 663, 10.1056/NEJM199709043371002 de Valk, 1995, Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial, Ann Intern Med, 123, 1, 10.7326/0003-4819-123-1-199507010-00001 Meyer, 1995, Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study, Thromb Haemost, 74, 1432, 10.1055/s-0038-1649960 Anderson, 1992, Thrombolytic therapy for the treatment of acute pulmonary embolism, Can Med Assoc J, 146, 1317 1970, Urokinase pulmonary embolism trial: phase 1 results; a cooperative study, JAMA, 214, 2163, 10.1001/jama.1970.03180120035007 1974, Urokinase-streptokinase embolism trial: phase 2 results; a cooperative study, JAMA, 229, 1606, 10.1001/jama.1974.03230500024021 Marder, 1979, The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring, Ann Intern Med, 90, 802, 10.7326/0003-4819-90-5-802 Goldhaber, 1988, Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9 Goldhaber, 1993, Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion, Lancet, 341, 507, 10.1016/0140-6736(93)90274-K Goldhaber, 1994, Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial: The Bolus Alteplase Pulmonary Embolism Group, Chest, 106, 718, 10.1378/chest.106.3.718 Meneveau, 1997, Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction, Eur Heart J, 18, 1141, 10.1093/oxfordjournals.eurheartj.a015410 Cella, 1987, Controversies of different regimens of thrombolytic therapy in acute pulmonary embolism, Semin Thromb Haemost, 13, 163, 10.1055/s-2007-1003488 Verstraete, 1988, Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism, Circulation, 77, 353, 10.1161/01.CIR.77.2.353 Levine, 1990, A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism, Chest, 98, 1473, 10.1378/chest.98.6.1473 Sharma, 1980, Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism, N Engl J Med, 303, 842, 10.1056/NEJM198010093031502 Carson, 1992, The clinical course of pulmonary embolism, N Engl J Med, 326, 1240, 10.1056/NEJM199205073261902 Tebbe, 1999, Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism, Am Heart J, 138, 39, 10.1016/S0002-8703(99)70243-7 Stewart, 1982, Transvenous vena caval filtration and pulmonary embolectomy, Surg Clin North Am, 62, 411, 10.1016/S0039-6109(16)42734-9 Greenfield, 1984, Surgical approaches to thromboembolism, Br J Surg, 71, 968, 10.1002/bjs.1800711220 Timsit, 1991, Pulmonary embolectomy by catheter device in massive pulmonary embolism, Chest, 100, 655, 10.1378/chest.100.3.655 Koning, 1997, A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy, Circulation, 96, 2498, 10.1161/01.CIR.96.8.2498 Fava, 1997, Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism, J Vasc Interv Radiol, 8, 261, 10.1016/S1051-0443(97)70552-9 Schmitz-Rode, 2000, Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter, J Am Coll Cardiol, 36, 375, 10.1016/S0735-1097(00)00734-8 Schmitz-Rode, 1998, Fragmentation of massive pulmonary embolism using a pigtail rotation catheter, Chest, 114, 1427, 10.1378/chest.114.5.1427 de Gregorio, 2001, Mechanical fragmentation and intrapulmonary fibrinolysis in the treatment of massive pulmonary embolism hemodynamic repercussions, Arch Bronconeumol, 37, 58, 10.1016/S0300-2896(01)75015-6 Tapson, 1994, Rapid visualization of massive pulmonary emboli utilizing intravascular ultrasound, Chest, 105, 888, 10.1378/chest.105.3.888 Meyer, 1991, Pulmonary embolectomy: a 20-year experience at one center, Ann Thorac Surg, 51, 232, 10.1016/0003-4975(91)90792-O Gray, 1988, Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases, Br Heart J, 60, 196, 10.1136/hrt.60.3.196 Clarke, 1986, Pulmonary embolectomy: a 25 year experience, J Thorac Cardiovasc Surg, 92, 442, 10.1016/S0022-5223(19)35798-8 Ullmann, 1999, The urgent pulmonary embolectomy: mechanical resuscitation in the operating theatre determines the outcome, Thorac Cardiovasc Surg, 47, 5, 10.1055/s-2007-1013099 Greenfield, 1999, Recommended reporting standards for vena caval filter placement and patient follow-up: Vena Caval Filter Consensus Conference, J Vasc Interv Radiol, 10, 1013, 10.1016/S1051-0443(99)70185-5 Greenfield, 1993, Long-term experience with transvenous catheter pulmonary embolectomy, J Vasc Surg, 18, 450, 10.1016/0741-5214(93)90263-L Greenfield, 2000, The percutaneous Greenfield filter: outcomes and practice patterns, J Vasc Surg, 32, 888, 10.1067/mva.2000.110346 Fink, 1991, The Greenfield filter as the primary means of therapy in venous thromboembolic disease, Surg Gynecol Obstet, 172, 253 Leach, 1994, Surgical prophylaxis for pulmonary embolism, Am Surg, 60, 292 Dorfman, 1990, Percutaneous inferior vena caval filters, Radiology, 174, 987, 10.1148/radiology.174.3.174-3-987 Hubbard, 1994, The Bird's Nest filter: an alternative to long-term oral anticoagulation in patients with advanced malignancies, Am J Clin Oncol, 17, 115, 10.1097/00000421-199404000-00005 Lord, 1994, Early and late results after Bird's Nest filter placement in the inferior vena cava: clinical and duplex ultrasound follow up, Aust N Z J Surg, 64, 106, 10.1111/j.1445-2197.1994.tb02154.x Murphy, 1991, LGM vena cava filter: objective evaluation of early results, J Vasc Interv Radiol, 2, 107, 10.1016/S1051-0443(91)72482-2 Millward, 1994, LGM (Vena Tech) vena caval filter: experience at a single institution, J Vasc Interv Radiol, 5, 351, 10.1016/S1051-0443(94)71501-3 Bull, 1992, Gunther vena caval filter: clinical appraisal, J Vasc Interv Radiol, 3, 395, 10.1016/S1051-0443(92)72052-1 Tola, 1999, Bedside placement of inferior vena cava filters in the intensive care unit, Am Surg, 65, 833, 10.1177/000313489906500906 Linsenmaier, 1998, Indications, management, and complications of temporary inferior vena cava filters, Cardiovasc Interv Radiol, 21, 464, 10.1007/s002709900305 Bovyn, 1997, The Tempofilter: a multicenter study of a new temporary caval filter implantable for up to six weeks, Ann Vasc Surg, 11, 520, 10.1007/s100169900084 Zwaan, 1998, Clinical experience with temporary vena caval filters, J Vasc Interv Radiol, 9, 594, 10.1016/S1051-0443(98)70328-8 Millward, 2001, Gunther Tulip retrievable vena cava filter: results from the Registry of the Canadian Interventional Radiology Association, J Vasc Interv Radiol, 12, 1053, 10.1016/S1051-0443(07)61590-5 Spence, 1999, Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters, Radiology, 210, 53, 10.1148/radiology.210.1.r99ja1353 Greenfield, 1998, Suprarenal filter placement, J Vasc Surg, 28, 432, 10.1016/S0741-5214(98)70128-4 Greenfield, 1991, Results of a multicenter study of the modified hook-titanium Greenfield filter, J Vasc Surg, 14, 253, 10.1016/0741-5214(91)90074-5 Rohrer, 1989, Extended indications for placement of an inferior vena cava filter, J Vasc Surg, 10, 44, 10.1016/0741-5214(89)90284-X Golueke, 1988, Interruption of the vena cava by means of the Greenfield filter: expanding the indications, Surgery, 103, 111 Cohen, 1991, Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer, Surgery, 109, 12 Calligaro, 1991, Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement, Ann Vasc Surg, 5, 186, 10.1007/BF02016754 Emerson, 1991, Prophylactic and early therapeutic use of the Greenfield filter in hip and knee joint arthroplasty, J Arthroplasty, 6, 129, 10.1016/S0883-5403(11)80007-0 Sarasin, 1993, Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business, J Gen Intern Med, 8, 476, 10.1007/BF02600108 Rogers, 1993, Prophylactic vena cava filter insertion in severely injured trauma patients: indications and preliminary results, J Trauma, 35, 637, 10.1097/00005373-199310000-00021 Rosenthal, 1994, Use of the Greenfield filter in patients with major trauma, Cardiovasc Surg, 2, 52 Webb, 1992, Greenfield filter prophylaxis of pulmonary embolism in patients undergoing surgery for acetabular fracture, J Orthop Trauma, 6, 139, 10.1097/00005131-199206000-00002 Collins, 1992, Vena caval filter use in orthopaedic trauma patients with recognized preoperative venous thromboembolic disease, J Orthop Trauma, 6, 135, 10.1097/00005131-199206000-00001 Cotroneo, 1996, Venous interruption as prophylaxis of pulmonary embolism: vena cava filters, Rays, 21, 461 Ascher, 2000, Lessons learned from a 6-year clinical experience with superior vena cava Greenfield filters, J Vasc Surg, 32, 881, 10.1067/mva.2000.110883 Rousseau, 2001, The 6-F nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial, J Vasc Interv Radiol, 12, 299, 10.1016/S1051-0443(07)61907-1 Athanasoulis, 2000, Inferior vena caval filters: review of a 26-year single-center clinical experience, Radiology, 216, 54, 10.1148/radiology.216.1.r00jl1254 Mertens, 1998, Inferior vena cava filters: indications and results in 111 patients, Rev Med Chile, 126, 655 The Matisse Investigators, 2003, Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism, N Engl J Med, 349, 1695, 10.1056/NEJMoa035451 Heit, 1999, Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study, Arch Intern Med, 159, 445, 10.1001/archinte.159.5.445 Agnelli, 2003, Extended oral anticoagulant therapy after a first episode of pulmonary embolism, Ann Intern Med, 139, 19, 10.7326/0003-4819-139-1-200307010-00008 Jamieson, 2000, Pulmonary endarterectomy, Curr Probl Surg, 37, 165, 10.1016/S0011-3840(00)80005-2 Masuda, 2001, Our experience of surgical treatment for chronic pulmonary thromboembolism, Ann Thorac Cardiovasc Surg, 7, 261 Mayer, 1997, Early results of pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension, Z Kardiol, 86, 920, 10.1007/s003920050132 Gilbert, 1998, Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy, World J Surg, 22, 1029, 10.1007/s002689900511 Miller, 1998, Reperfusion edema after thromboendarterectomy: radiographic patterns of disease, J Thorac Imaging, 13, 178, 10.1097/00005382-199807000-00003 Dartevelle, 1999, Angioscopic video-assisted pulmonary endarterectomy for post-embolic pulmonary hypertension, Eur J Cardiothorac Surg, 16, 38, 10.1016/S1010-7940(99)00116-5 Ando, 1999, Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients, J Card Surg, 14, 377, 10.1111/j.1540-8191.1999.tb01014.x Mares, 2000, Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies, Anesth Analg, 90, 267, 10.1213/00000539-200002000-00006 Rubens, 2000, Surgical treatment of chronic thromboembolic pulmonary hypertension, Can Respir J, 7, 49, 10.1155/2000/496809 D'Armini, 2000, Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes, Eur J Cardiothorac Surg, 18, 696, 10.1016/S1010-7940(00)00584-4 Tscholl, 2001, Pulmonary thromboendarterectomy: risk factors for early survival and hemodynamic improvement, Eur J Cardiothorac Surg, 19, 771, 10.1016/S1010-7940(01)00686-8 Fedullo, 2001, Chronic thromboembolic pulmonary hypertension, N Engl J Med, 345, 1465, 10.1056/NEJMra010902 McLaughlin, 1999, Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series, Ann Intern Med, 130, 740, 10.7326/0003-4819-130-9-199905040-00014 Mo, 1999, Reoperative pulmonary thromboendarterectomy, Ann Thorac Surg, 68, 1770, 10.1016/S0003-4975(99)01043-7 Becherucci, 2000, Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion, Med Clin (Barc), 114, 371, 10.1016/S0025-7753(00)71300-5 Bergqvist, 1990, Treatment of superficial thrombophlebitis: a comparative trial between placebo, Hirudoid cream and piroxicam gel, Ann Chir Gynaecol, 79, 92 Superficial Thrombophlebitis Treated by Enoxaparin Study Group, 2003, A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis, Arch Intern Med, 163, 1657, 10.1001/archinte.163.14.1657 Titon, 1994, Therapeutic management of superficial venous thrombosis with calcium nadroparin: dosage testing and comparison with a non-steroidal anti-inflammatory agent, Ann Cardiol Angeiol (Paris), 43, 160 Marchiori, 2002, High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg: a prospective, controlled, randomized study, Haematologica, 87, 523 Belcaro, 1999, Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study, Angiology, 50, 523, 10.1177/000331979905000701 Burihan, 1993, Upper-extremity deep venous thrombosis: analysis of 52 cases, Cardiovasc Surg, 1, 19, 10.1177/096721099300100106 Goldstein, 1976, Les thromboses veineuses du membre supérieur, Schweiz Rundsch Med Prax, 65, 1450 Hingorani, 2001, Combined upper and lower extremity deep venous thrombosis, Cardiovasc Surg, 9, 472, 10.1016/S0967-2109(01)00039-4 Lindblad, 1988, Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae, Eur J Vasc Surg, 2, 161, 10.1016/S0950-821X(88)80069-0 Marinella, 2000, Spectrum of upper-extremity deep venous thrombosis in a community teaching hospital, Heart Lung, 29, 113, 10.1067/mhl.2000.105758 Savage, 1999, Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity, Thromb Haemost, 82, 1008, 10.1055/s-0037-1614319 Marie, 1998, Upper-extremity deep venous thrombosis: a report of 49 cases, Rev Med Intern, 19, 399, 10.1016/S0248-8663(98)80864-3 Feugier, 2001, Long-term results of venous revascularization for Paget-Schroetter syndrome in athletes, Ann Vasc Surg, 15, 212, 10.1007/s100160010043 Horne, 2000, Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities, Am J Med, 108, 251, 10.1016/S0002-9343(99)00407-6 Lokanathan, 2001, Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosis, J Vasc Surg, 33, 783, 10.1067/mva.2001.112708 Machleder, 1993, Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein, J Vasc Surg, 17, 305, 10.1016/0741-5214(93)90416-J Massoure, 2000, Thromboses veineuses profondes des members supérieurs, J Mal Vasc, 25, 250 Pegis, 1997, Thrombolyse in situ dans le traitement des thromboses veineuses d'effort du membre supérieur, J Mal Vasc, 22, 187 Petrakis, 2000, Two different therapeutic modalities in the treatment of the upper extremity deep vein thrombosis: preliminary investigation with 20 case reports, Int J Angiol, 9, 46, 10.1007/BF01616331 Yilmaz, 2000, Long-term results of local thrombolysis followed by first rib resection: an encouraging clinical experience in treatment of subclavian vein thrombosis, Vasc Surg, 34, 17, 10.1177/153857440003400105 Lee, 1998, Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: an effective treatment approach, J Vasc Surg, 27, 1101, 10.1016/S0741-5214(98)70012-6 Sanders, 1995, Surgical management of subclavian vein obstruction, including six cases of subclavian vein bypass, Surgery, 118, 856, 10.1016/S0039-6060(05)80276-4 Ascer, 1996, Superior vena caval Greenfield filters: indications, techniques, and results, J Vasc Surg, 23, 498, 10.1016/S0741-5214(96)80017-6 Prandoni, 1999, Upper extremity deep vein thrombosis, Curr Opin Pulm Med, 5, 222, 10.1097/00063198-199907000-00008 Buller, 2004, Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial, 140, 867